Medigard selects site for trials
Thursday, 10 July, 2008
Medical device company Medigard [ASX; MGZ] will conduct clinical trials of its proprietary safety blood collection devices at Griffith University's Gold Coast campus.
The trials will be held at the university's Genomics Research Centre. 500 of the devices have been delivered to the centre for simulated clinical trials.
The trials are part of the company's FDA 510(k) application, a fast-tracking process for important, innovative or advanced medical devices.
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
